Drug Profile
Research programme: PPAR agonists - LG Chem
Alternative Names: PPAR agonistsLatest Information Update: 17 Aug 2017
Price :
$50
*
At a glance
- Originator LG Life Sciences
- Class
- Mechanism of Action Peroxisome proliferator-activated receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Type-2-diabetes-mellitus in South Korea
- 11 Apr 2007 Preclinical trials in Type-2 diabetes mellitus in South Korea (unspecified route)